Atrial fibrillation (AFib) isn’t just disruptive — it can affect daily life, raise stroke risk, and lead to long-term complications. In this episode of The Pulse Report, Dr. Shen, a cardiologist specializing in electrophysiology and the Director of Research and Education at Cardiovascular Medicine (CVM), takes you inside one of the most exciting advances in rhythm care: pulsed field ablation (PFA).

Traditional ablation has long been a cornerstone of AFib treatment, but it relies on heat or cold, which can sometimes affect nearby tissues. PFA uses short electrical pulses that precisely target only the misfiring heart cells — making it safer, faster, and more selective.

Recent studies, including the ADVENT trial (The New England Journal of Medicine, 2023) and early registries in Circulation and Journal of the American College of Cardiology, show that PFA is at least as effective as older methods, but with fewer complications.

You’ll learn:

• What pulsed field ablation (PFA) is, and how it differs from traditional approaches.
• What to expect before, during, and after the procedure.
• Why major trials like EAST-AFNET 4, EARLY-AF, and CABANA show that ablation often provides better rhythm control and quality of life than medications alone.
• Why ablation isn’t always a permanent “cure,” and what it means when AFib comes back.
• How the 2023 ACC/AHA/HRS AFib Guidelines position ablation as a strong rhythm-control option, while emphasizing individualized care.
• Real-world stories of how restoring rhythm helps people regain energy, confidence, and quality of life.

This A Day in the Life of an Electrophysiologist episode takes you behind the scenes of PFA, blending cutting-edge research with day-to-day practice. It highlights what patients, families, and doctors should know about this new option—and why shared decision-making is key to finding the right treatment path.

If you or a loved one is living with AFib, this episode offers clarity and evidence-based guidance to help you explore whether pulsed field ablation might be right for you.

Follow us on YouTube: https://www.youtube.com/@ThePulseReportWithDrShen

Read more:
-Reddy VY, et al. (2023). Pulsed Field or Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation | New England Journal of Medicine
-Kirchhof P, et al. (2020). Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. | New England Journal of Medicine
-Andrade JG, et al. (2020). Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation. | New England Journal of Medicine
-Packer DL, Mark DB, Robb RA, et al. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.
-2023 ACC/AHA/HRS Guideline for the Management of AFib. | Circulation.

Let's keep your heart — and your life — going strong and in rhythm.

For people living with atrial fibrillation (AFib), one of the greatest concerns is the risk of stroke. Traditionally, that risk is managed with blood thinners such as Eliquis, Xarelto, or Warfarin. More recently, the WATCHMAN device has provided another option, sealing off the left atrial appendage where most clots form.

Now, a major international clinical trial — LAAOS-4— is testing what happens when we combine these two approaches, blood thinners plus WATCHMAN. Could the combination provide even stronger protection against stroke and cognitive decline?

In this episode of The Pulse Report, Dr. Shen explains:

• How LAAOS-4 builds on earlier research showing surgical closure of the left atrial appendage plus blood thinners reduces stroke risk.
• Why high-risk patients may benefit most from combining medical and device-based protection.
• What participation in the trial looks like — from randomization to minimally invasive WATCHMAN implantation to memory and brain health follow-up.
• How this global collaboration of 4,000 patients could shape the future of AFib care and stroke prevention worldwide.
• Why the Quad Cities community is proud to be part of this groundbreaking research.

This Innovation Update episode takes you inside one of the most important AFib trials underway today — and what it could mean for the way doctors and patients approach stroke prevention in the years ahead.

If you or a loved one has AFib and a high stroke risk, this episode offers clarity, context, and insights you can take to your next cardiology conversation.

Let's keep your heart — and your life — going strong and in rhythm.

Living with atrial fibrillation (AFib) means more than coping with an erratic heartbeat—it means facing the twin challenges of maintaining rhythm and avoiding stroke.

In this Innovation Update from The Pulse Report, Dr. Shen, a cardiologist specializing in electrophysiology and the Director of Research and Education at Cardiovascular Medicine (CVM), explores a new approach that addresses both problems in a single procedure.

This episode takes you inside one of the most exciting advances in AFib care: combining pulsed field ablation (PFA) with WATCHMAN device implantation during the same session.

You’ll discover:

• What PFA is and how it works: An ablation technique that uses short electrical pulses—rather than heat or cold—to precisely target abnormal tissue while reducing the risk of damage to surrounding structures.
• What the WATCHMAN does: A small implant that seals off the heart’s left atrial appendage, the area where most AFib-related clots form, lowering stroke risk without requiring lifelong blood thinners.
• Why combining them matters: Patients receive rhythm control and stroke protection in one procedure, with fewer hospital visits, reduced anesthesia use, and a quicker return to daily life.
• Who might benefit most from this combined approach, and how it is already transforming care in the Quad Cities and beyond.
• What early evidence shows: Research has shown that PFA and WATCHMAN are safe and effective treatment options on their own; now, emerging data and new reimbursement support are paving the way for combined use when it makes sense.
• A real patient story that shows how innovation in medicine is not just about technology, but about restoring quality of life.

If you or a loved one are living with AFib, this episode offers clarity, confidence, and insights to guide conversations with your cardiologist.

Let's keep your heart — and your life — going strong and in rhythm.